Stock Investing
What Is The Reason Behind Novocure (NVCR) Stock Increasing 67% Pre-Hours Session?
Following positive results from its research to treat malignancies, NovoCure Limited (NASDAQ: NVCR) shares jumped 67.57% to $118.19 on Thursday morning. Which NVCR study had fruitful outcomes? The LUNAR study showed a statistically significant and clinically significant increase in overall survival above conventional therapy alone,
